Historical development of health technology assessment in Thailand Teerawattananon Y*, Tantivess S*, Yothasamut J*, Kingkaew P *, Chaisiri K*. *Health Intervention and Technology Assessment Program, Thailand Objectives This study aims to review the development of health technology assessme

Over the past 5 years, HCUs (i.e., top 5% of the population) utilized ~50% of the annual health expenditure, confirming that even during the pandemic year of 2020, the HCU phenomenon still existed. The characteristics of HCU patients remained relatively the same from 2016 to 2020, in terms of pro

Two days after Debra Demidon underwent in vitro fertilization, she gained more than 30 pounds in fluid and suddenly was struggling to breathe.Doctors diagnosed severe ovarian hyperstimulation syndrome (OHSS), a complication seen in some women who undergo fertility treatment. It landed Ms. Demidon in

The diagnosis is indisputable: Thailand’s healthcare services must be reformed. The Finance Ministry’s latest proposal to let insurance companies take over the government’s role in providing healthcare coverage for state officials and their families seems like a bandage solution. Thailand’s spending

Reference: Tarn YH, Hu S, Kamae I, Yang BM, Li SC, Tangcharoensathien V, Teerawattananon Y, Limwattananon S, Hameed A, Aljunid SM, Bapna JS. Health-care systems and pharmacoeconomic research in Asia-Pacific region. Value Health. 2008;11(Suppl 1):S137-55. Link: http://www.ncbi.nlm.nih.gov/pubme

Health technology assessments as a mechanism for increased value for money: recommendations to the Global Fund. Yot Teerawattananon1*, Kate McQueston2, Amanda Glassman2, Jomkwan Yothasamut1,2 and Chaw Yin Myint1,2 Abstract The Global Fund is experiencing increased pressure to optimize resul

Kalipso Chakidou1*, Ryan Li1, Anthony J. Culyer2, Amanda Glassman3, Karen J. Hofman4, Yot Teerawattananon5 1Institute of Global Health Innovation, Imperial College London, London, UK 2Department of Economics & Related Studies and Centre for Health Economics, University of York, York, UK 3Ce

Abstract Cost-effectiveness analysis (CEA) can help countries attain and sustain universal health coverage (UHC), as long as it is context-specific and considered within deliberative processes at the country level. Institutionalising robust deliberative processes requires significant time and res